EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Universal Microfluidic Platform for Multifunctional Surface Modification of Small Extracellular Vesicles

Yanhang Hong, Huitao Zhang, Lin Zeng, Yicheng Wang, Yan You, Jienan Shen, Rui Hao, Lianyu Lu, Shi Hu, Zitong Yu, Cong Li, Hui Yang iD

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2025. Verfasst von Yanhang Hong und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biomedical Imaging Science and System, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Techno…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Microfluidics, Lab-On-A-Chip Devices. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small Extracellular vesicles (sEVs) hold great promise as therapeutic delivery vehicles due to their inherent biocompatibility. However, their clinical translation is limited by donor cell source dependency and inadequate targeting capabilities. To overcome these challenges, we introduce a universal surface engineering strategy that integrates lipid membrane anchoring with targeted ligand conjugation. At the core of this approach is the sEV Surface‐Engineering microfluidic device (ExoSE), a dual‐functional platform combining nanofluidic and microfluidic architectures. ExoSE consists of two interconnected modules: (1) a loading module that employs mechanoporation via nanochannels to transiently generate pores in sEV membranes, enabling highly efficient insertion of functionalized lipids and (2) a mixing module with specialized structures that facilitate rapid, covalent attachment of targeting ligands via optimized chemical reactions. This approach achieved lipid incorporation efficiencies of 97.93% for HEK293T‐dervied sEVs and 98.47% for milk‐derived sEVs, surpassing conventional co‐incubation techniques. NanoFCM analysis revealed a 3‐ to 6‐fold increase in ligand binding per sEV. Functionally, RGE peptide‐modified sEVs exhibited a 54.13% increase in transmembrane transport efficiency in the in vitro model and enhanced infiltration into glioma spheroid, while AS1411 aptamer‐conjugated sEVs showed 77.8% targeting specificity towards breast cancer cells, compared to 32.5% for normal breast cells. In vivo tracking in BALB/c‐nude mice confirmed significantly improved brain accumulation of engineered sEVs, with no detectable hepatic or renal toxicity. Unlike traditional donor‐cell‐dependent genetic modification approaches, ExoSE enables universal, scalable modification of sEVs from diverse sources, including highly abundant milk‐derived sEVs, and accommodates diverse ligand types such as peptides, aptamers and proteins. This device represents a transformative advancement in sEV engineering, establishing a standardized and scalable framework for precision‐targeted sEV therapeutics with enhanced clinical potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMicrofluidicsLab-On-A-Chip DevicesHumansAnimalsMiceHEK293 CellsFemaleDrug Delivery Systems

Autor:innen und Institutionen

  • State Key Laboratory of Biomedical Imaging Science and System, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, School of Pharmacy, Fudan University, Shanghai, China.

ORCID-Profile: Hui Yang

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Hong, Y., Zhang, H., Zeng, L., Wang, Y., You, Y., Shen, J., Hao, R., Lu, L., Hu, S., Yu, Z., Li, C., & Yang, H. (2025). Universal Microfluidic Platform for Multifunctional Surface Modification of Small Extracellular Vesicles. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70215

Vancouver

Hong Y, Zhang H, Zeng L, Wang Y, You Y, Shen J, et al. Universal Microfluidic Platform for Multifunctional Surface Modification of Small Extracellular Vesicles. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70215

BibTeX
@article{Hong2025,
  author = {Hong, Yanhang and Zhang, Huitao and Zeng, Lin and Wang, Yicheng and You, Yan and Shen, Jienan and Hao, Rui and Lu, Lianyu and Hu, Shi and Yu, Zitong and Li, Cong and Yang, Hui},
  title = {Universal Microfluidic Platform for Multifunctional Surface Modification of Small Extracellular Vesicles},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70215}
}
Kostenlos starten →